Martin Jechlinger
Group Leader
Cell Biology and Biophysics
European Molecular Biology Laboratory
Germany
Biography
PhD 2002, Institute of Molecular Pathology (IMP) Vienna. Postdoctoral research at Memorial Sloan-Kettering Cancer Center (MSKCC) New York. Group leader at EMBL Monterotondo 2010-15. Group leader at EMBL Heidelberg since 2015.
Research Interest
-
Publications
-
Koehler C, Sauter PF, Wawryszyn M, Girona GE, Gupta K, Landry JJ, Fritz MH, Radic K, Hoffmann JE, Chen ZA, Zou J, Tan PS, Galik B, Junttila S, Stolt-Bergner P, Pruneri G, Gyenesei A, Schultz C, Biskup MB, Besir H, Benes V, Rappsilber J, Jechlinger M, Korbel JO, Berger I, Braese S, Lemke EA. (2016) Genetic code expansion for multiprotein complex engineering. Nat. Methods doi: 10.1038/nmeth.4032
-
Weischenfeldt J., Dubash T., Drainas A., Mardin B., Chen Y., Stütz A., Waszak S., Bosco G., Halvorsen A., Raeder B., Efthymiopoulos T., Erkek S., Siegl C., Brenner H., Brustugun O., Dieter S., Northcott P., Petersen I., Pfister S., Schneider M., Solberg S., Thunissen E., Weichert W., Zichner T., Thomas R., Peifer M., Helland A., Ball C., Jechlinger M., Sotillo R., Glimm H., Korbel J.. (2016) Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking Nature Genetics doi: 10.1038/ng.3722
-
Havas KM, Milchevskaya V, Radic K, Alladin A, Kafkia E, Garcia M, Stolte J, Klaus B, Rotmensz N, Gibson TJ, Burwinkel B, Schneeweiss A, Pruneri G, Patil KR, Sotillo R, Jechlinger M. (2017) Metabolic shifts in residual breast cancer drive tumor recurrence J Clin Invest 127(6):2091-2105. doi: 10.1172/JCI89914
